Skip to main content
OSTEOPORE LIMITED logo

OSTEOPORE LIMITED — Investor Relations & Filings

Ticker · OSX ISIN · AU0000053324 ASX Manufacturing
Open in API
Filings indexed 488 across all filing types
Latest filing 2023-07-06 Director's Dealing
Country AU Australia
Listing ASX OSX

About OSTEOPORE LIMITED

https://osteopore.com

Osteopore Limited specializes in the design and manufacture of 3D-printed bioresorbable implants. The company utilizes a patented 3D printing process to create scaffolds from bioresorbable polymers, such as polycaprolactone, designed to mimic the natural microstructure of bone. These implants, including the Osteoplug, Osteomesh, and Osteostrip product lines, are applied in neurosurgical, craniofacial, and orthopedic procedures to facilitate bone healing and tissue regeneration. The scaffolds provide a temporary structural framework that supports the body's natural healing process before being gradually absorbed and replaced by the patient's own bone tissue. This technology aims to reduce long-term complications associated with permanent foreign implants by promoting natural tissue integration and restoration across various clinical applications.

Recent filings

Filing Released Lang Actions
Rectification of Breach of ASX Listing Rule 10.11 1
Director's Dealing Classification · 95% confidence The document is an ASX release titled 'Rectification of Breach of ASX Listing Rule 10.11' dated 7 July 2023. It discusses the disposal of shares and options by Mr Leong to rectify a breach of a listing rule. It mentions an Appendix 3Y to be published recording the change in interests. The content focuses on insider share transactions and compliance with listing rules rather than financial results, management changes, or other report types. The document is short (1269 characters) and is an announcement of a transaction by a director, which fits the definition of Director's Dealing filings.
2023-07-06 English
Change of Director's Interest Notice - ML 3 pages 201.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details the change in securities holdings of a company director, including the number of shares and options disposed and held after the change. This is a report of personal share transactions by a company director, which fits the definition of 'Director's Dealing'. The document is not a financial report, earnings release, or any other type of report but specifically a notification of insider trades by a director.
2023-07-06 English
Application for quotation of securities - OSX 8 pages 32.9KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Application for quotation of +securities' and details the application for quotation of securities issued by Osteopore Limited. It includes information about the number and type of securities to be quoted, issue dates, distribution schedules, and references to previous announcements such as Appendix 3B. The document is an official announcement related to the listing or quotation of new securities on the ASX (Australian Securities Exchange). It does not contain financial statements, management discussion, or earnings data. It is not a report but an announcement regarding capital market activity, specifically the quotation of securities. Therefore, the document fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2023-06-28 English
Notice of Breach of ASX Listing Rule 10.11 2 pages 275.1KB
Regulatory Filings Classification · 95% confidence The document is an ASX release titled 'Notice of Breach of ASX Listing Rule 10.11' dated 26 June 2023. It discusses a breach related to a securities issue involving a related party without prior shareholder approval, referencing the ASX Listing Rules. The content focuses on the breach, corrective actions, and administrative review, with no financial statements or detailed financial data presented. The document is relatively short (3383 characters) and is an announcement about a regulatory compliance issue rather than a financial report or detailed management discussion. It does not fit categories like Annual Report, Interim Report, or Capital Update but aligns with regulatory announcements about compliance and governance matters. Therefore, the most appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-06-25 English
Change of Share Registry Details 2 pages 243.5KB
Regulatory Filings Classification · 95% confidence The document is an ASX release from Osteopore Limited dated 23 June 2023. It announces a change in the company's share registry service provider from Link Market Services to Automic Pty Ltd. The content focuses solely on administrative details about shareholder registry services and contact information. There is no financial data, report, or discussion of financial results, nor is there any mention of voting results, management changes, or capital structure changes. The document is relatively short (3343 characters) and serves as an announcement of a procedural change rather than a report or detailed filing. Therefore, it does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is best classified under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-06-22 English
Shortfall oversubscribed for Osteopore's Global Expansion 2 pages 317.6KB
Capital/Financing Update Classification · 95% confidence The document is an ASX release announcing the completion of a shortfall placement of shares following a non-renounceable entitlement offer. It details the number of shares issued, the issue price, options attached, and the use of proceeds for global expansion and R&D. There is no financial statement or detailed financial report included, only a capital raising update. The document length is 4576 characters, which is relatively short and focused on a financing event. This fits the definition of a Capital/Financing Update (CAP) rather than an Annual Report, Earnings Release, or other report types. Therefore, the correct classification is CAP with high confidence.
2023-06-19 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.